RGLS
Regulus Therapeutics
RGLS
RGLS
Delisted
RGLS was delisted on the 24th of June, 2025.
44 hedge funds and large institutions have $42.6M invested in Regulus Therapeutics in 2021 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 10 increasing their positions, 6 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
42% more funds holding
Funds holding: 31 → 44 (+13)
0.86% more ownership
Funds ownership: 2.9% → 3.76% (+0.86%)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
44
Holding in Top 10
–
Calls
$702K
Puts
$134K
Top Buyers
| 1 | +$4.42M | |
| 2 | +$3.71M | |
| 3 | +$3.1M | |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$2.69M |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
+$1.94M |
Top Sellers
| 1 | -$4.56M | |
| 2 | -$2.17M | |
| 3 | -$606K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$119K |
| 5 |
BlackRock
New York
|
-$81.8K |